Vicarious Surgical (RBOT) Long-Term Debt Repayments (2022 - 2023)
Vicarious Surgical (RBOT) reported Long-Term Debt Repayments of $4000.0 for Q2 2023, down 97.33% year-over-year from $150000.0 in Q2 2022, and down 66.67% on a QoQ basis from $12000.0 in Q1 2023.
Vicarious Surgical (RBOT) has 2 years of Long-Term Debt Repayments data on file, last reported at $4000.0 in Q2 2023.
- Quarterly Long-Term Debt Repayments fell 97.33% year-over-year to $4000.0 in Q2 2023, while the trailing twelve-month figure through Dec 2023 was $16000.0 (down 98.81% YoY) and the FY2023 annual result came in at $16000.0, down 98.81% from the prior year.
- Long-Term Debt Repayments eased to $4000.0 in Q2 2023 per RBOT's latest filing, from $12000.0 in the prior quarter.
- Across five years, Long-Term Debt Repayments topped out at $900000.0 in Q4 2022 and bottomed at $4000.0 in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.42 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.00 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Dec 31, 2022 | 900,000.00 |
| Dec 31, 2022 | 900,000.00 |
| Sep 30, 2022 | 150,000.00 |
| Sep 30, 2022 | 150,000.00 |
| Jun 30, 2022 | 150,000.00 |
| Jun 30, 2022 | 150,000.00 |
| Mar 31, 2022 | 150,000.00 |
| Mar 31, 2022 | 150,000.00 |